Therapeutic Potential of Antimicrobial Peptides in Polymicrobial Biofilm-Associated Infections

Area of Science:

• Microbiology
• Infectious Diseases
• Biochemistry

Background:

• Many chronic human infections, such as diabetic foot ulcers and cystic fibrosis lung infections, involve multiple microbial species (polymicrobial etiology).
• These polymicrobial communities often form biofilms, which are resistant to conventional antimicrobial treatments and host immune responses.
• Interactions within these microbial communities can alter virulence and susceptibility to antimicrobials, complicating treatment strategies.

Purpose of the Study:

• To provide a comprehensive review of the therapeutic potential of antimicrobial peptides (AMPs) in treating mixed microbial infections.
• To highlight the advantages and limitations of using AMPs against polymicrobial infections.

Main Methods:

• Literature review of studies investigating AMPs against polymicrobial infections.
• Analysis of AMP mechanisms of action in the context of microbial communities and biofilms.
• Evaluation of existing research on AMP efficacy and challenges in clinical applications.

Main Results:

• Antimicrobial peptides (AMPs) exhibit broad-spectrum activity and unique mechanisms that may be effective against polymicrobial infections.
• AMPs can disrupt biofilms and modulate host immune responses, offering potential advantages over traditional antibiotics.
• However, challenges remain regarding AMP stability, delivery, and potential resistance development in complex microbial communities.

Conclusions:

• AMPs represent a promising therapeutic avenue for combating challenging polymicrobial infections.
• Further research and development are crucial to overcome existing limitations and fully realize the clinical potential of AMPs.
• Targeting multiple pathogens simultaneously with AMPs could revolutionize the treatment of chronic and complex infections.